The way I look at this is if there are no additional safety concerns, FDA are not fussing too much over efficacy given emergence of new variants. I am not a huge advocate of boosting teens but since omicron evades 2 dose efficacy to a good extent, FDA's expedited decision seems correct in hindsight. $Pfizer(PFE)$
精彩评论